BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10881743)

  • 1. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
    Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
    Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN/MMAC1 expression in melanoma resection specimens.
    Deichmann M; Thome M; Benner A; Egner U; Hartschuh W; Näher H
    Br J Cancer; 2002 Dec; 87(12):1431-6. PubMed ID: 12454773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
    Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK
    Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
    Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
    Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PTEN tumour suppressor gene and malignant melanoma.
    Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
    Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PTEN mutations in metastatic melanoma specimens.
    Celebi JT; Shendrik I; Silvers DN; Peacocke M
    J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
    Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
    Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer.
    Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH
    Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
    Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
    Moritake H; Horii Y; Kuroda H; Sugimoto T
    Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression.
    Poetsch M; Dittberner T; Woenckhaus C
    Cancer Genet Cytogenet; 2001 Feb; 125(1):21-6. PubMed ID: 11297763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
    Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
    J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
    Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
    J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutation of PTEN in bladder carcinoma.
    Aveyard JS; Skilleter A; Habuchi T; Knowles MA
    Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.